Paradice Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-148,650
Closed -$13.7M 25
2024
Q4
$13.7M Sell
148,650
-77,827
-34% -$7.64M 2.72% 20
2024
Q3
$21.9M Sell
226,477
-20,564
-8% -$1.85M 3.81% 15
2024
Q2
$21.2M Sell
247,041
-7,048
-3% -$591K 3.75% 15
2024
Q1
$21M Sell
254,089
-172,656
-40% -$12.6M 3.64% 14
2023
Q4
$28.5M Sell
426,745
-372,186
-47% -$24.1M 3.58% 12
2023
Q3
$53.7M Sell
798,931
-34,923
-4% -$2.4M 4.6% 8
2023
Q2
$56.5M Sell
833,854
-16,729
-2% -$1.05M 4.2% 9
2023
Q1
$46M Sell
850,583
-1,010
-0.1% -$58.8K 3.5% 14
2022
Q4
$50.9M Hold
851,593
3.95% 11
2022
Q3
$38.5M Sell
851,593
-200,650
-19% -$10M 3.28% 15
2022
Q2
$46.9M Buy
1,052,243
+214,573
+26% +$11M 3.59% 10
2022
Q1
$47.4M Buy
+837,670
New +$43.7M 2.77% 16

Other funds holding EHC

Paradice Investment Management's EHC Position: Q1 2025 in Review

Paradice Investment Management sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 148,650 shares — an estimated $13.7M sold.

Paradice Investment Management first reported a position in EHC in Q1 2022 and held it in 12 quarters. The position peaked at $56.5M in Q2 2023. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Paradice Investment Management reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • Paradice Investment Management sold 148,650 Encompass Health shares in Q1 2025, an estimated $13.7M.
  • Paradice Investment Management first reported a position in Encompass Health in Q1 2022 and held it in 12 quarters.
  • Paradice Investment Management's Encompass Health position peaked at $56.5M in Q2 2023.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Paradice Investment Management's 13F filing for Q1 2025, filed 12 May 2025.